After splitting at the median value, higher circ-BAX-18 expression was rather associated with poorer disease-free survival (<i>p</i> = 0.009) and overall survival (<i>p</i> = 0.012) of BrCa patients. This evidence concerns the gene BAX and invasive breast carcinoma.